Cargando…

Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting

AIM: To describe trends of combination therapy (CT) of infliximab (IFX) and immunomodulator (IMM) for inflammatory bowel disease (IBD) in the community setting. METHODS: A retrospective study was conducted of all IBD patients referred for IFX infusion to our community infusion center between 04/01/0...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berkowitz, Joshua C, Stein-Fishbein, Joanna, Khan, Sundas, Furie, Richard, Sultan, Keith S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797978/ https://www.ncbi.nlm.nih.gov/pubmed/29430323 http://dx.doi.org/10.4292/wjgpt.v9.i1.8

Ejemplares similares

Combination therapy for inflammatory bowel disease
por: Sultan, Keith S, et al.
Publicado: (2017)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
por: Bohra, Anuj, et al.
Publicado: (2020)

Correlation of abnormal histology with endoscopic findings among mycophenolate mofetil treated patients
por: Izower, Mitchell A, et al.
Publicado: (2017)

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
por: Halling, Morten L, et al.
Publicado: (2017)

Role of telomere shortening in anticipation of inflammatory bowel disease
por: Truta, Brindusa, et al.
Publicado: (2020)

Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified
por: Monteiro, Sara, et al.
Publicado: (2017)

Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
por: Ma, Hai-Qin, et al.
Publicado: (2018)

Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease
por: Horvat, Natally, et al.
Publicado: (2016)

Frequency, types, and treatment of anemia in Turkish patients with inflammatory bowel disease
por: Bengi, Göksel, et al.
Publicado: (2018)

Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
por: Gordon, Benjamin Langan, et al.
Publicado: (2022)

Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
por: Haider, Maryam Bilal, et al.
Publicado: (2023)

Bowel inflammatory presentations on computed tomography in adult patients with severe aplastic anemia during flared inflammatory episodes
por: Zhao, Xi-Chen, et al.
Publicado: (2023)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022)

Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective
por: Pallav, Kumar, et al.
Publicado: (2017)

Analysis of the clinical indications for opiate use in inflammatory bowel disease
por: Gao, Youran, et al.
Publicado: (2017)

Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene
por: Ohya, Takashi, et al.
Publicado: (2017)

Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases
por: Su, Wen, et al.
Publicado: (2021)

Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil
por: Martins, Adalberta Lima, et al.
Publicado: (2022)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

Efficacy of ileus tube combined with meglumine diatrizoate in treating postoperative inflammatory bowel obstruction after surgery
por: Yang, Wen, et al.
Publicado: (2023)

A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
por: Lichtenstein, Gary R, et al.
Publicado: (2012)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
por: Lew, Daniel, et al.
Publicado: (2017)

Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with de novo inflammatory bowel disease
por: Bajer, Lukas, et al.
Publicado: (2018)

Serological investigation of IgG and IgE antibodies against food antigens in patients with inflammatory bowel disease
por: Wang, Hai-Yang, et al.
Publicado: (2019)

Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
por: Lee, Jooyoung, et al.
Publicado: (2019)

Apolipoprotein E variants correlate with the clinical presentation of paediatric inflammatory bowel disease: A cross-sectional study
por: Glapa-Nowak, Aleksandra, et al.
Publicado: (2021)

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients
por: Wei, Hong-Tao, et al.
Publicado: (2023)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease
por: Guerra Veloz, María Fernanda, et al.
Publicado: (2018)

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis
por: Hoffmann, Peter, et al.
Publicado: (2020)

Effect of small bowel transit time on accuracy of video capsule endoscopy in evaluating suspected small bowel bleeding
por: Mohan, Nandakumar, et al.
Publicado: (2022)

Fecal lactoferrin accurately reflects mucosal inflammation in inflammatory bowel disease
por: Rubio, Marrieth G, et al.
Publicado: (2019)

Split-dose bowel preparation improves adequacy of bowel preparation and gastroenterologists’ adherence to National Colorectal Cancer Screening and Surveillance Guidelines
por: Menees, Stacy Bartnik, et al.
Publicado: (2018)

Clinical observation of Kuntai capsule combined with Fenmotong in treatment of decline of ovarian reserve function
por: Lin, Xin-Miao, et al.
Publicado: (2021)

Real-world data on the infliximab biosimilar CT-P13 (Remsima(®)) in inflammatory bowel disease
por: Huguet, Jose María, et al.
Publicado: (2021)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease
por: Spekhorst, Lieke M, et al.
Publicado: (2017)

Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
por: Yao, Ling-Ya, et al.
Publicado: (2022)

Cholinergic immunomodulation in inflammatory bowel diseases
por: Serafini, Michele A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ahmhietqsg0jf2321e0rjvpmip